The excellent paper by Arbab-Zadeh et al. (1) highlights the issues surrounding imaging coronary artery disease in the presence of a high calcium score; however, we are concerned that the outcome, at least in part, may result from statistical artifact.
First, the negative predictive value of cardiac computed tomography in the setting of a calcium score Ͼ600 was based on a subgroup of only 8 patients, with error margins far too large to draw robust conclusions.
Second, although it is implicitly assumed that measurement by invasive coronary angiography is both perfectly accurate and immutable, neither assumption is correct. The reproducibility of angiographic coronary stenosis measurement has a standard deviation of approximately 13% (2), whereas comparison with intravascular ultrasound results in a standard error of up to 26% (3). Failure to account for imperfections in the reference standard may result in significant error in the assessed accuracy of a comparator test (4) . Even minor errors in the reference standard are greatly magnified when a high disease prevalence (5) or multiple lesions near the positive threshold value are observed. Consistent with this effect, computed tomography coronary angiography in patients with high calcium and patients with known coronary artery disease (prevalence 88% and 84%, respectively) had poor negative predictive values. If intravascular ultrasound were similarly compared with an imperfect quantitative coronary angiography reference in a population with an average of 2 coronary segments within the 40% to 50% stenosis range, the negative predictive value would be falsely estimated to be Ͻ50%. It would be incorrect to claim on this basis that intravascular ultrasound is inaccurate in populations with a high disease prevalence. Equally, estimates of the accuracy of computed tomography coronary angiography in comparison with unadjusted quantitative angiography should be treated with great caution.
Reply
We thank Dr. Otton and colleagues for their interest in our paper (1) and their insightful comments. We agree with Dr. Otton and colleagues that the poor negative predictive value in the group of patients with a calcium score of Ͼ600 was driven by the fact that only 8 patients did not have obstructive coronary artery disease. However, we believe this is not a "statistical artifact" but the expected result in a patient population with high pre-test probability of disease. According to Bayes' theorem, post-test probability of no disease with a negative test result is low with high pre-test probability of disease. It was an important objective of our study to demonstrate this very effect in a large cohort of patients with different pre-test probabilities of disease.
We agree with Dr. Otton and colleagues in regard to the limitations of conventional angiography as the gold standard (2). We also agree that intravascular ultrasound would be a more appropriate gold standard for the assessment of coronary arterial lumen obstruction. Unfortunately, conventional angiography is still being regarded as the reference standard for clinical and research purposes, and we adhered to this standard for this study. Equal or improved patient outcome based on computed tomography coronary artery assessment in comparison with conventional angiography will eventually lead to accepting computed tomography angiography as a valid alternative to conventional angiography. 
Poorly Compressible Leg Arteries: A Specific Presentation of Peripheral Artery Disease
We commend Arain et al. (1) for their elegant study comparing the survival of patients with peripheral artery disease (PAD) and poorly compressible arteries (PCA) who were referred to their vascular laboratory. They supported previous findings, in both the general population and the clinical setting, that individuals with a very high ankle-brachial index (ABI) are at increased risk of mortality (2,3). They also suggested that patients with PCA have a poorer prognosis compared with patients with PAD. This assertion may be due to some misinterpretations and residual confounding factors. Actually, their PAD group included patients with mild disease who had an ABI at rest Ͼ0.90 but Ͻ0.90 after 1 minute of exercise. Also, they calculated ABI by taking the lowest ankle artery pressure, so those who had only 1 diseased ankle artery were included in the PAD group, whereas to be included in the PCA group, patients should have both ankle arteries stiffened. Altogether, the authors were more sensitive to include mild PAD, but very specific to define PCA. The authors redid the analyses taking the highest pressure between ankle arteries, decreasing the hazard ratio for mortality in case of PCA versus PAD, at the limits of statistical significance. It is unclear how patients with PAD in one limb but PCA in the other limb were classified. This situation has been observed in 10% of diabetic patients who were referred to our vascular laboratory (3) .
In their multivariate analysis, the authors might have missed 2 residual confounding factors: First, the models were adjusted to medications at baseline, but patients with PAD might have received more preventive treatments after the diagnosis, including statins, antiplatelet drugs, and angiotensin-converting enzyme inhibitors, compared with patients with PCA, because at that time the increased risk of the latter group was unknown. Of note, the use of angiotensin-converting enzyme inhibitors has not been included in the models. A recent analysis of the National Health and Nutrition Examination Survey cohort showed that patients with an ABI Ͻ0.90 who took at least 2 of the 3 drug groups mentioned would have an improved prognosis (4). Second, beyond adjustments for age and diabetes-2 major risk factors for PCAthe duration of diabetes per se is an independent factor associated with this condition (3,5), a factor not studied by the authors.
Finally, the authors show that the coexistence of PAD as revealed by Doppler is an independent predictor of mortality in patients with PCA, in line with our study (3) . Whether patients with isolated PCA remained at increased risk of mortality compared with the PAD group has not been addressed. We found that diabetic patients with PCA without concomitant PAD had a survival equivalent to that of patients with normal ABI (3). In their series, a substantial proportion of patients with PCA had critical limb ischemia, twice as frequent as in the PAD group. We believe that the higher risk reported in patients with PCA versus PAD is related to a high proportion of concomitant severe PAD in the PCA group, compared with less severe disease in the PAD group. 
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